Value-Based Cancer Care at the ACCC National Oncology Conference
Panelists at the 2014 Association of Community Cancer Centers (ACCC) National Meeting explore the costs and value in cancer care. Moderated by... Learn More
Value in Cancer Care—2014 ACCC Meeting
Panelists at the 2014 Association of Community Cancer Centers (ACCC) National Meeting explore the costs and value in cancer care. Moderated by... Learn More
Continuous Innovation against Cancer: It’s Real, It’s Valuable — but It’s Too Slow
To accelerate the research that leads to new cancer treatments, we need policies that support continuous innovation. Hear more from Eli Lilly... Learn More
Newt Crenshaw on Assessing the Value of Cancer Treatments
Newt Crenshaw, Vice President of Oncology at Lilly, explains the importance of coming together and having a conversation about the issues associated... Learn More
Dr. Richard Gaynor: The Future of Cancer Care
How can continuous innovation transform the lives of the 13 million Americans living with cancer?
Accelerating Cancer Innovation through Clinical Trials
Clinical trials stand out as one of the most important elements in the development of a new cancer medicine. Conducting clinical trials... Learn More
ASCO’s First-Ever Clinical Trial: The TAPUR Study
The Targeted Agent and Profiling Utilization Registry (TAPUR) study is evaluating molecularly targeted cancer drugs and collecting data on clinical outcomes to... Learn More